Emergence of circulating MicroRNAs in breast cancer as diagnostic and therapeutic efficacy biomarkers

V Aggarwal, K Priyanka, HS Tuli - Molecular diagnosis & therapy, 2020 - Springer
Breast cancer is the second most common cause of deaths reported in women worldwide,
and therefore there is a need to identify breast cancer patients at an early stage as timely …

Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers

R Hamam, D Hamam, KA Alsaleh, M Kassem… - Cell death & …, 2017 - nature.com
Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

Circulating miRNAs in breast cancer diagnosis and prognosis

B Cardinali, R Tasso, P Piccioli, MC Ciferri, R Quarto… - Cancers, 2022 - mdpi.com
Simple Summary In the era of precision medicine, new tools for better management of breast
cancer patients are still needed. From this perspective, circulating microRNA (miRNA), a …

[HTML][HTML] MicroRNAs and its emerging role as breast cancer diagnostic marker-A review

SA Bhat, S Majid, T Hassan - Advances in Biomarker Sciences and …, 2019 - Elsevier
Breast cancer causes severe mental stress on the affected woman during investigation,
diagnosis and treatment as breast is regarded as a symbol of beauty, sexuality and …

[HTML][HTML] Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: Quo vadis?

GS Christodoulatos, M Dalamaga - World journal of clinical …, 2014 - ncbi.nlm.nih.gov
Breast cancer (BC) is the most frequent type of non skin cancer among women and a major
leading cause of cancer-related deaths in Western countries. It is substantial to discover …

A new insight on serum microRNA expression as novel biomarkers in breast cancer patients

Z Bahmanpour, R Sheervalilou… - Journal of Cellular …, 2019 - Wiley Online Library
Breast cancer (BC) is one of the widespread lethal diseases affecting a large number of
women worldwide. As such, employing and identifying significant markers for detecting BC …

The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs

A Bahrami, A Aledavood, K Anvari… - Journal of cellular …, 2018 - Wiley Online Library
Breast cancer is the second most common malignancy diagnosed in women, supporting the
need for identification of novel prognostic and diagnostic biomarkers. Recently, microRNAs …

microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection

R Hamam, AM Ali, KA Alsaleh, M Kassem, M Alfayez… - Scientific reports, 2016 - nature.com
Breast cancer (BC) is the most common cancer type and the second cause of cancer-related
death among women. Therefore, better understanding of breast cancer tumor biology and …

MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction

FJ Nassar, R Nasr, R Talhouk - Pharmacology & therapeutics, 2017 - Elsevier
Breast cancer is a major health problem that affects one in eight women worldwide. As such,
detecting breast cancer at an early stage anticipates better disease outcome and prolonged …

Circulating microRNAs as prognostic and therapeutic biomarkers in breast cancer molecular subtypes

V Zelli, C Compagnoni, R Capelli, K Cannita… - Journal of personalized …, 2020 - mdpi.com
Breast cancer (BC) is a common and heterogeneous disease, of which six molecular
subtypes, characterized by different biological features and clinical outcomes, were …